Glucocorticoids (GCs) induce profound hyperphagia in birds. However, the neuronal regulatory network underlying GC-provoked hyperphagia is unclear. To determine whether any cross talk occurs among hypothalamic GC receptors (GRs), AMP-activated protein kinase (AMPK), and GCs in the regulation of appetite, we performed an intracerebroventricular injection of mifepristone (a GR inhibitor) and compound C (an AMPK inhibitor) on GC-treated male chicks. T he central nervous system plays an important role in energy homeostasis and feeding behavior in mammals, as well as in birds, and contains a complex neuronal network within the hypothalamus that regulates appetite and energy balance (1, 2). As in mammals, 2 primary populations of neurons that influence appetite through the release of signaling molecules exist in the hypothalamus of avian Among the orexigenic peripheral signals are glucocorticoids (GCs), the final product of hypothalamic-pituitary-adrenal axis activation in response to stress. In addition, GCs play a permissive role in the regulation of energy balance. The intracerebroventricular (icv) injection of dexamethasone (DEX) (a synthetic GC) was determined to increase food intake and body weight in rats and ring doves (5, 6). GC receptors (GRs) are located in the hypothalamic nuclei and are essential for energy balance regulation (7). In mountain chickadees, corticosteroneimplanted birds cached and consumed significantly more food, suggesting that moderate chronic elevation of corticosterone may serve as an adaptation to unpredictable environments by facilitating feeding and food-caching behavior in food-caching birds (8). Moreover, there is an association between behavior and corticosterone within the physiological range in modern selected broiler breeders as well (9). GCs stimulate NPY expression while restraining POMC synthesis and release in both avian and mammalian species (5, 10).
T he central nervous system plays an important role in energy homeostasis and feeding behavior in mammals, as well as in birds, and contains a complex neuronal network within the hypothalamus that regulates appetite and energy balance (1, 2) . As in mammals, 2 primary populations of neurons that influence appetite through the release of signaling molecules exist in the hypothalamus of avian species: orexigenic neuropeptides (eg, neuropeptide Y [NPY] and agouti-related peptide [AgRP]) (2) and anorexigenic neuropeptides (eg, proopiomelanocortin [POMC] , cocaine and amphetamine-regulated transcript [CART] , CRH, and melanocortin receptor 4 [MC4R]) (3, 4) . Peripheral signals reflecting energy balance are supposed to be integrated at the hypothalamic arcuate nucleus (ARC).
Among the orexigenic peripheral signals are glucocorticoids (GCs), the final product of hypothalamic-pituitary-adrenal axis activation in response to stress. In addition, GCs play a permissive role in the regulation of energy balance. The intracerebroventricular (icv) injection of dexamethasone (DEX) (a synthetic GC) was determined to increase food intake and body weight in rats and ring doves (5, 6) . GC receptors (GRs) are located in the hypothalamic nuclei and are essential for energy balance regulation (7) . In mountain chickadees, corticosteroneimplanted birds cached and consumed significantly more food, suggesting that moderate chronic elevation of corticosterone may serve as an adaptation to unpredictable environments by facilitating feeding and food-caching behavior in food-caching birds (8) . Moreover, there is an association between behavior and corticosterone within the physiological range in modern selected broiler breeders as well (9) . GCs stimulate NPY expression while restraining POMC synthesis and release in both avian and mammalian species (5, 10) .
AMP-activated protein kinase (AMPK), a key indicator of the physiological energy state, is allosterically activated by an increase in the intracellular AMP/ATP ratio, as well as by the phosphorylation of Thr172 by upstream kinases (11) . Recent studies suggest that hypothalamic AMPK signaling pathways are involved in the regulation of energy balance (12) . In mammals, icv injection of 5-aminoimidazole-4-carboxamide-1-␤-d-ribofuranoside, an AMPK activator, activated the NPY neurons of ARC to increase food intake in rats (13) . In contrast, icv injection of com-pound C, an AMPK inhibitor, induced anorexia in mice (14) . Christ-Crain et al (15) determined that in vivo or in vitro GC treatment increased AMPK activity in the rat hypothalamus, which was thought to be associated with GC-induced hyperphagia. In vitro, Shimizu et al (16) demonstrated that GCs up-regulate hypothalamic NPY and AgRP gene expression in rats through AMPK signaling, at least in part. In poultry, hypothalamic AMPK signaling can be activated under fasting conditions (17) and can be affected by various peripheral signals related to energy balance, including insulin, leptin, and ghrelin (18, 19) . However, whether AMPK is involved in GC-induced hyperphagia in chickens remains unknown.
In the present study, we examined the changes in appetite-related peptides in the hypothalamus of broiler chicks after icv DEX injection and determined the relationship between AMPK and GR signaling and the DEXinduced hyperphagia by blocking AMPK and GR.
Materials and Methods

Animals
One-day-old male broiler chicks were obtained from a local hatchery and housed in cages in an environmentally controlled room. The brooding temperature was maintained at 35°C for the first 2 days and then gradually decreased to 31°C by day 10. The light regime was 23 hour light, 1 hour dark. All chicks received a starter diet containing 21.5% crude protein and 12.33 MJ/kg of metabolizable energy (20) . All birds had free access to food and water during the rearing period. This study was approved by the Shandong Agricultural University and carried out in accordance with the Guidelines for Experimental Animals of the Ministry of Science and Technology (Beijing, China).
Implantation of icv cannulae
At 7 days of age, chicks of similar body weight (165 Ϯ 5 g) were anesthetized by iv injection in the wing vein with pentobarbital sodium at a dose of 25 mg/kg body weight. The chicks were mounted with the stereotaxy apparatus (Huai Bei Zheng Hua), and a small incision was made in the flesh along the midline. The thin-walled stainless steel guide cannula was stereotaxically implanted into the third ventricle as described by Puelles et al (21) . The chicks were allowed at least 3 days of recovery before injection (22) .
Intracerebroventricular injection and verification
At each injection, an internal injection cannula that extended 1 mm past the guide cannula was inserted, and all injections were administered using a 10-L Hamilton syringe controlled by a microinjection pump. After the infusion, the guide cannula was maintained for approximately 30 seconds to allow the drugs to diffuse away from the cannula tip, and the dummy cannula was then reinserted. All of the injection drugs and vehicle contained 0.1% Evans blue solution to facilitate injection site localization. After data collection, the chicks were decapitated, and the heads were sectioned along the frontal plane to determine the site of injection. Any chick without dye present in the third ventricle was eliminated from analysis.
Effects of icv infusion of DEX on food intake
After 3 days of recovery, 24 broiler chicks of similar body weight (220 Ϯ 5 g) were randomly divided into 4 groups, 6 replicates per group, and 1 chick per replicate. All chicks were individually housed and fasted for 3 hours before experiment. The chicks received an icv injection (2 L/injection) of 0, 1, 2, or 4 g of DEX (dissolved in saline) and were granted immediate access to food. Food intake was recorded every 0.5 hours after injection by weighing the feeder. The scattered food under feeder was collected, weighed, and deducted from food intake.
Effects of icv infusion of DEX on AMPK signaling and appetite-related gene expression
To observe the effects of the icv infusion of DEX on AMPK signaling and appetite-related gene expression, the birds received an icv injection (2 L/injection) of 4 g of DEX or vehicle. After continuous fasting for 3 hours, the chicks were killed by exsanguination. The hypothalamus was dissected from the ventral surface of the brain. Two transverse cuts were made at the apex of the optic chiasm and the rostral margin of the mammillary bodies. Next, 2-mm bilateral cuts were made on either side of the midline, and the whole hypothalamus was removed according to the method described in Yuan et al (23) . The cut was 4 -5 mm deep parallel to the base of the brain (24) . After being snap frozen in liquid nitrogen, the hypothalamus tissue samples were stored at Ϫ80°C until RNA and protein extraction.
Effects of icv infusion of compound C on food intake
To observe the time and dose-dependent effects of compound C (Calbiochem), which is known to inhibit AMPK signaling, on food intake, the chicks received an icv injection (2 L/injection) of 0, 4, 6, or 10 g of compound C or vehicle (PBS) and were granted immediate access to food. Food intake was recorded after every 0.5 hours.
Effects of AMPK signaling blockade on food intake and NPY mRNA expression after icv infusion with DEX
To assess the effects of AMPK signaling blockade on food intake and NPY gene expression in chicks stimulated with DEX, the chicks were fasted for 3 hours and then icv injected with either compound C (6 g/2 L) or vehicle (dimethyl sulfoxide, 2 L). After 1.5 hours, the birds were given an icv injection of either 4-g DEX or saline, and food intake was recorded thereafter. The experiment was repeated twice. During the second experiment, the chicks were continuously fasted for 3 hours after DEX administration, and the hypothalami were collected.
Effects of GR blockade on food intake, NPY mRNA expression, and AMPK signaling after icv infusion with DEX
To assess the effects of GR blockade on food intake, NPY mRNA expression, and AMPK signaling stimulated by DEX, the chicks were fasted for 3 hours and then icv injected with either mifepristone (RU486) (60 g/2 L; Sigma), a synthetic competitive steroid receptor inhibitor (25) , or vehicle (dimethyl sulfoxide, 2 L). After 0.5 hours, the birds were given an icv injection of either 4-g DEX or saline. The food intake was recorded after every 0.5 hours. The experiment was repeated twice. During the second experiment, the chicks were continuously fasted for 3 hours after DEX administration, and the hypothalami were collected.
RNA isolation and analysis
Gene expression in the hypothalamus was quantified using quantitative real-time PCR. Total RNA was isolated with TRIzol (Invitrogen). The quality and the quantity of the RNA was determined by agarose-gel electrophoresis and using a biophotometer (Eppendorf). Reverse transcription reactions (10 L) contained 500-ng total RNA, 5 mmol/L MgCl 2 , 1-L RT buffer, 1 mmol/L deoxyribonucleoside triphosphate, 2.5-U avian myeloblastosis virus, 0.7 nmol/L oligo d(T), and 10-U ribonuclease inhibitor (TaKaRa). Real-time PCR analysis was conducted using the Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems). Each RT reaction served as a template in a 20-L PCR containing 0.2 mol/L of each primer and SYBR Green Master mix (TaKaRa). The primer sequences are listed in Table 1 . The primers were designed for exon-intron junctions using Primer 5.0 software. The real-time PCRs were performed at 95°C for 10 seconds of predenaturation, followed by 40 cycles consisting of denaturation at 95°C for 5 seconds and annealing and extension at 60°C for 40 seconds. A standard curve was plotted to calculate the efficiency of the real-time PCR primers. ␤-Actin was used as the housekeeping gene, and the results of the relative mRNA quantification were verified with glyceraldehyde 3-phosphate dehydrogenase levels (⌬cycle threshold [⌬CT] ). The comparative CT method(2 Ϫ⌬⌬CT ) was used to quantitate mRNA expression in accordance with Livak and Schmittgen (26) . The specificity of the amplification product was verified with melting curve analysis and DNA sequencing.
Protein preparation and Western blotting
The protein concentration was determined using a bicinchoninic acid assay kit (Beyotime). After boiling at 100°C, the protein extracts (80 g) were electrophoresed in 7.5%-10% sodium dodecyl sulfate polyacrylamide gels following the procedure described by Laemmli (27) . The separated proteins were then transferred onto nitrocellulose membranes at 100 V at 4°C. Thereafter, the membrane was stripped for doing the assay of phosphorylated proteins and actin separately. The membranes were blocked and immunoblotted with the following primary antibodies: phospho-AMPK␣ Thr172 antibody, AMPK␣ antibody, phospho-acetyl-coenzyme A carboxylase (ACC) Ser79 antibody, and ACC antibody. These antibodies were validated previously for use with chicken samples (28, 29) . Protein detection was performed using goat antirabbit IgG (heavy and light chains)-horseradish peroxidase-conjugated secondary antibody (Bio-Rad) or horseradish peroxidase-labeled goat antimouse IgG (heavy and light chains) secondary antibody by enhanced chemiluminescence using Western blotting detection reagents (Beyotime). Monoclonal mouse anti-␤-actin antibody was used as a loading control. Western blottings were developed and quantified using BioSpectrum 810 with VisionWorksLS 7.1 software (UVP LLC).
Statistical analysis
The data are presented as the mean Ϯ SEM. Homogeneity of variances among the treatments was confirmed using Bartlett's test. All data were subjected to one-way ANOVA analysis to test the main effect of the treatment (n ϭ 6). When the main effect of the treatment was significant, the differences between means were assessed by Duncan's multiple range analysis. P Ͻ .05 was considered statistically significant.
Results
Effects of icv DEX infusion on food intake, AMPK signaling, and appetite-related genes expression
Central DEX treatment (1-4 g) induced a dose-dependent increase in food intake ( Figure 1) . The mRNA and protein expression were measured in 4-g DEX administration group, and the results indicated that icv injection of 4-g DEX was associated with higher ratios of AMPK␣ and ACC phosphorylation than in the control chicks (P Ͻ .05) (Figure 2 , A and B). Intracerebroventricular DEX treatment had no significant effect on the mRNA levels of AgRP, POMC, CART, MC4R, and CRH in the hypothalamus (P Ͼ .05) (Figure 2, C and D) . However, the gene expression of NPY, GR, and carnitine palmitoyltransferase-1 (CPT1) was significantly up-regulated after central DEX treatment (P Ͻ .05) ( Figure 2E ).
Effects of icv infusions of compound C on food intake
Intracerebroventricular administration of 6-g compound C induced a significantly decrease in food intake at 1.5-2 hours after injection (P Ͻ .05), but this effect was not observed for 10 g (P Ͼ .05). In contrast, icv-given compound C (4 g) significantly decreased food intake at 1.5 hours after injection (P Ͻ .05) (Figure 3) .
Effects of AMPK signaling blockade on food intake and NPY gene expression after icv infusion of DEX
The food intake and mRNA and protein levels were determined after icv administration of 6-g compound C. Pretreatment with compound C significantly attenuated the higher food intake caused by DEX compared with the , and (D) the mRNA levels of GR and CPT1 in chicks exposed to DEX or saline. The values are expressed as the mean Ϯ SEM (for food intake, protein, and mRNA levels, n ϭ 6). ab, The means differ significantly (P Ͻ .05).
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Liu et al AMPK Involved in GC-Induced Hyperphagia Endocrinology, June 2014, 155(6):2190 -2198 DEX treatment (P Ͻ .05) ( Figure 4A ). Intracerebroventricular injection with compound C significantly decreased the levels of the phosphorylated AMPK␣ and ACC proteins and NPY gene (P Ͻ .05) compared with the control. Additionally, pretreatment with compound C significantly suppressed the DEX-stimulated expression of AMPK␣, ACC, and NPY compared with the DEX treatment alone (P Ͻ .05) (Figure 4 , B-D). Although compound C did not significantly affect the phosphorylation level or mRNA level of CPT1 (P Ͼ .05), the stimulatory effects of DEX on CPT1 gene expression were significantly attenuated in the presence of compound C (P Ͻ .05) ( Figure 4D ).
Effects of GR blockade on food intake, NPY mRNA expression, and AMPK signaling after icv infusion of DEX As shown in Figure 5A , central pretreatment with RU486 significantly attenuated the increased food intake caused by DEX. For RU486-treated chicks, the levels of AMPK␣ and ACC phosphorylation, as well as the NPY level, were not significantly different from the control group (P Ͼ .05) ( Figure 5, B-D) . However, pretreatment with RU486 significantly reduced the DEX-induced variation in the levels of phosphorylated AMPK␣ and ACC and CPT1 level (P Ͻ .05) ( Figure 5 , B-D) and tended to decrease the NPY level (P ϭ .0756) ( Figure 5D ).
Discussion
In the present study, we investigated which hypothalamic peptides are involved in the hyperphagia of chicks after an icv infusion of DEX and whether the AMPK pathway is involved. Our data demonstrated that 1) GCs induce hyperphagia of chicks by increasing NPY level in the hypothalamus, 2) the inhibition of AMPK signaling attenuates hyperphagia and the NPY expression stimulated by GCs, and 3) the inhibition of GR partially suppresses hyperphagia, NPY gene expression, and AMPK pathway induced by GCs. The results suggest that GCs stimulate food intake via the AMPK pathway in chicks ( Figure 6 ).
DEX increased food intake by up-regulating NPY mRNA levels
In line with a previous report in birds (5) , the present data demonstrate that icv DEX injection resulted in increased food intake in a dose-dependent manner. This result was in agreement with previous report that showed peripheral GCs administration stimulated food intake (30) .
Compared with the vehicle-infused controls, chicks receiving icv NPY administration exhibited marked hyperphagia (31) . In present study, the increased hypothalamic lev- endo.endojournals.orgels of NPY after central continuous GCs infusion in chicks was similar to previous reports in birds and rats (5, 32) , which suggest that NPY is associated with GC-induced hyperphagia. Uchoa et al (33) reported that adrenalectomy in wildtype mice repressed the mRNA levels of AgRP and POMC and increased the CRH level. Shimizu et al (16) found that GCs increase AgRP gene expression in hypothalamic cultures of rats. The CRH and AgRP mRNA levels in present work were not significantly changed by DEX, suggesting the different susceptibility of the CRH and AgRP signals in response to GCs between birds and mammals. Here, we observed that the POMC mRNA level was increased (P ϭ .118). Hypothalamic NPY and POMC neurons form a coordinate network (34) . In the daily patterns of hypothalamic neuropeptides of rats, POMC gene expression displayed a different time course from NPY and elevated 4 hours later than NPY mRNA level (35) . In mammals, leptin increases the frequency of action potentials in the anorexigenic POMC neurons by reducing the inhibition of local orexigenic NPY neurons (36) . Therefore, the increased trend of POMC mRNA after DEX treatment may be a result from stimulated NPY neurons. Similarly, the MC4R and CART neurons may not be the primary targets in DEX-induced hyperphagia of chicks. All the data suggest DEX increased food intake only through the regulation of orexigenic NPY gene expression, not through anorexigenic neuropeptides.
DEX induced hyperphagia in a partially GR-dependent manner
Although GCs exert their effects after binding to the cytoplasmic GR (37) , it has also been demonstrated that some effects of GCs on cellular responses are independent of gene transcription (38, 39) . In accordance with a previous study (5), GR transcription was enhanced after DEX exposure, suggesting that the regulatory role of GCs was enhanced. To further examine whether DEX induced hyperphagia in a GR-dependent manner, the synthetic competitive steroid receptor inhibitor RU486 was used. The DEX-induced increase in food intake and up-regulation of NPY expression were significantly suppressed by RU486 treatment, suggesting that DEX increases food intake by up-regulating NPY mRNA level in a GR-dependent manner. However, because the stimulating effect of GCs was not fully abolished by RU486, the direct regulation of GCs cannot be excluded.
AMPK is involved in DEX-induced hyperphagia through the up-regulation of NPY mRNA levels
In line with a previous study (5) , icv GCs infusions significantly increased AMPK phosphorylation, suggesting that AMPK might be involved in the hyperphagia induced by DEX. The activation or blockade of AMPK signaling at the hypothalamus level has been shown to affect NPY and AgRP expression in the ARC of rats both in vivo and vitro (16, 40) . Several hormonal and nutrient signals, including ghrelin and insulin, affect AMPK signaling of hypothalamus (1, 18) , and the coordinated regulation of hypothalamic AMPK signaling is believed to play a critical role in energy homeostasis (12) .
To further determine the potential role of inhibiting AMPK in the hypothalamus during DEX-induced hyperphagia, AMPK signaling was blocked by icv compound C injection. The stimulatory effects of DEX on food intake and NPY gene expression were significantly attenuated by the blockade of AMPK signaling, suggesting that GCs stimulate NPY gene expression via AMPK signaling.
The hypothalamic regulation of fatty acid metabolism has been found to mediate appetite and energy homeostasis induced by AMPK (41) . AMPK catalyzes the phosphorylation of ACC and, in turn, diminishes malonyl-CoA, which is an allosteric inhibitor of CPT1 (11) . In mammals, the downstream target of AMPK, ACC/malonyl-CoA, is involved in the regulation of food intake (12) . In our study, the levels of phospho-ACC level at Ser79 and CPT1 mRNA were enhanced by DEX treatment and were attenuated by compound C administration, suggesting that ACC and CPT1 are the downstream targets of the AMPK signaling pathway in both chicken and mammals.
We next investigated whether the effect of GCs on hypothalamic AMPK signaling was dependent on GR. We examined the phosphorylation level of AMPK after icv DEX injection after central pretreatment with RU486. Pretreatment with RU486 significantly inhibited the DEX-induced variation in AMPK␣ and ACC phosphorylation, as well as in the expression of the CPT1 and NPY genes, suggesting that GR is associated with the regulation of DEX via AMPK signaling. Furthermore, the stimulating effect of GCs the on phosphorylation of AMPK and ACC was not fully abolished by RU486 treatment. These results implied that GC regulates food intake by directly stimulating AMPK pathway and in a GR-dependent manner. Additionally, RU486 treatment increased the ACC concentration by 11.7%. Although this effect had no statistical significance (P ϭ .630) as the big variance within the treatment (coefficient of variance ϭ 19.7%), the result implied that RU486 may influence, at least in part, the levels of phosphor-ACC levels by increasing ACC concentration. In contrast, DEX treatment decreased the total ACC protein level by 15% (P ϭ .659; coefficient of variance ϭ 13.8%) (Figure 2) . The big variances in the effect of DEX and RU486 on ACC protein expression may imply that there is difference between individuals in the effect of GR-mediated GCs on the phospho-ACC/ ACC pathway, which deserves to be investigated further.
In conclusion, we demonstrated that GCs induce hyperphagia in chicks through the activation of the hypothalamic AMPK-NPY signaling pathway and preclude a more definitive interpretation of the effect of GRmediated GCs on the phospho-ACC/ACC pathway. The activation of AMPK signaling by GCs may be essential for the integration of various signals related to energy balance.
